AlinaƱera, Leticia T.
HRN: 24-88-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/16/2024
04/23/2024
IV
1.5 Grams
Every 8hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes